Copenhagen Centre for Regulatory Science, Department of Pharmacy, Faculty of Health and Medical Science, University of Copenhagen, Copenhagen, Denmark.
Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, Netherlands.
BMJ Open. 2020 May 11;10(5):e036498. doi: 10.1136/bmjopen-2019-036498.
To assess whether direct to healthcare professional communications (DHPCs) are of sufficient quality to be applicable in clinical practice and study how the quality differs according to safety concerns and type of monitoring.
Retrospective cohort study.
DHPCs containing monitoring instructions were identified among all DHPC issued in Denmark between 2007 and 2018.
Quality of information of monitoring instructions was assessed according to the Systematic Information for Monitoring (SIM) score. Associations between different characteristics of instructions and the SIM score were compared with analysis of variance and the post hoc test Tukey's honestly significant difference if significant.
In total, 297 DHPCs were issued, of which 97 contained 134 monitoring instructions. For 95% of these DHPCs the European Medicines Agency was involved. The average SIM score was 2.6±1.6 (ranging 0-6) and only 47% were considered of sufficient quality (SIM score ≥3). In addition, even fewer (11%) instructions were considered a 'adequate instruction' which also reported about facts and risks. Differences between quality of information according to type of monitoring were observed, specifically between clinical monitoring (average SIM score 1.9) and biomarker monitoring (physical average SIM score 2.9, p=0.029 and laboratory average SIM score 3.4, p<0.0001).
Monitoring instructions were found not to be of sufficient quality to be applicable in clinical practice according to the SIM score. Our study concludes the need for further research and regulatory steps to ensure improve quality of information in safety communications.
评估直接面向医疗保健专业人员的沟通(DHPC)是否具有足够的质量,以便在临床实践中应用,并研究其质量如何根据安全问题和监测类型而有所不同。
回顾性队列研究。
在 2007 年至 2018 年期间,在丹麦发布的所有 DHPC 中,确定了包含监测说明的 DHPC。
根据监测系统信息(SIM)评分评估监测说明的信息质量。比较不同特征的指令与 SIM 评分之间的关联,使用方差分析和事后检验 Tukey Honestly Significant Difference(如果显著)。
共发布了 297 份 DHPC,其中 97 份包含 134 份监测说明。这些 DHPC 中有 95%涉及欧洲药品管理局。平均 SIM 评分为 2.6±1.6(范围 0-6),只有 47%被认为具有足够的质量(SIM 评分≥3)。此外,认为信息质量“足够”的指令(即报告事实和风险的指令)更少(11%)。根据监测类型的不同,观察到信息质量的差异,特别是在临床监测(平均 SIM 评分 1.9)和生物标志物监测(物理平均 SIM 评分 2.9,p=0.029 和实验室平均 SIM 评分 3.4,p<0.0001)之间。
根据 SIM 评分,监测说明的质量不足以在临床实践中应用。我们的研究得出结论,需要进一步研究和监管措施,以确保安全通信中信息质量的提高。